BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/24/2020 7:25:57 AM | Browse: 650 | Download: 1570
 |
Received |
|
2020-05-28 06:08 |
|
Peer-Review Started |
|
2020-05-28 06:08 |
|
First Decision by Editorial Office Director |
|
2020-07-25 23:31 |
|
Return for Revision |
|
2020-07-25 23:31 |
|
Revised |
|
2020-08-10 04:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-09-04 07:08 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-09-05 01:46 |
|
Articles in Press |
|
2020-09-05 01:46 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-09-23 02:21 |
|
Publish the Manuscript Online |
|
2020-09-24 06:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anuj Bohra, Qurat-Al-Ain Rizvi, Charlotte Yuen Yu Keung, Abhinav Vasudevan and Daniel R van Langenberg |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anuj Bohra, BMed, Doctor, Doctor, Research Fellow, Department of Gastroenterology, Eastern Health, 3 West, 8 Arnold Street, Box Hill 3128, Victoria, Australia. anujbohra@hotmail.com |
| Key Words |
Inflammatory bowel disease; Infliximab; Safety; Cost; Therapy; Drug reaction |
| Core Tip |
Home-based infliximab infusions are a potential avenue to address overburdened infusion centres, yet enhance patient convenience. However, this depends on more rapid infusions, minimal risk of reactions and at no increased cost. This study provides a safety-centric, how-to guide for transitioning from standard 2-h hospital-based to rapid 30-min home-based infliximab infusions. An additional layer of safety is provided by careful patient selection; this study found that lower body mass index (< 22 kg/m2), presence of extraintestinal manifestation (s), longer disease duration (> 3 years) and previous biologic exposure were associated with an increased likelihood of reaction (s) to rapid maintenance infliximab infusions. |
| Publish Date |
2020-09-24 06:20 |
| Citation |
Bohra A, Rizvi QAA, Keung CYY, Vasudevan A, van Langenberg DR. Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability. World J Gastroenterol 2020; 26(36): 5437-5449 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i36/5437.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i36.5437 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
